Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 290(3): 1395-403, 2015 Jan 16.
Article in English | MEDLINE | ID: mdl-25429105

ABSTRACT

Complex sphingolipids are important components of eukaryotic cell membranes and, together with their biosynthetic precursors, including sphingoid long chain bases and ceramides, have important signaling functions crucial for cell growth and survival. Ceramides are produced at the endoplasmic reticulum (ER) membrane by a multicomponent enzyme complex termed ceramide synthase (CerS). In budding yeast, this complex is composed of two catalytic subunits, Lac1 and Lag1, as well as an essential regulatory subunit, Lip1. Proper formation of ceramides by CerS has been shown previously to require the Cka2 subunit of casein kinase 2 (CK2), a ubiquitous enzyme with multiple cellular functions, but the precise mechanism involved has remained unidentified. Here we present evidence that Lac1 and Lag1 are direct targets for CK2 and that phosphorylation at conserved positions within the C-terminal cytoplasmic domain of each protein is required for optimal CerS activity. Our data suggest that phosphorylation of Lac1 and Lag1 is important for proper localization and distribution of CerS within the ER membrane and that phosphorylation of these sites is functionally linked to the COP I-dependent C-terminal dilysine ER retrieval pathway. Together, our data identify CK2 as an important regulator of sphingolipid metabolism, and additionally, because both ceramides and CK2 have been implicated in the regulation of cancer, our findings may lead to an enhanced understanding of their relationship in health and disease.


Subject(s)
Casein Kinase II/metabolism , Gene Expression Regulation, Fungal , Membrane Proteins/metabolism , Oxidoreductases/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Amino Acid Motifs , Amino Acid Sequence , Catalytic Domain , Ceramides/metabolism , Endoplasmic Reticulum/metabolism , Humans , Microscopy, Fluorescence , Molecular Sequence Data , Phosphorylation , Plasmids/metabolism , Recombinant Proteins/metabolism , Signal Transduction , Sphingolipids/chemistry
2.
Pharmacogenet Genomics ; 22(12): 877-86, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23076370

ABSTRACT

OBJECTIVE: To advance our understanding of disease biology, the characterization of the molecular target for clinically proven or new drugs is very important. Because of its simplicity and the availability of strains with individual deletions in all of its genes, chemogenomic profiling in yeast has been used to identify drug targets. As measurement of drug-induced changes in cellular metabolites can yield considerable information about the effects of a drug, we investigated whether combining chemogenomic and metabolomic profiling in yeast could improve the characterization of drug targets. BASIC METHODS: We used chemogenomic and metabolomic profiling in yeast to characterize the target for five drugs acting on two biologically important pathways. A novel computational method that uses a curated metabolic network was also developed, and it was used to identify the genes that are likely to be responsible for the metabolomic differences found. RESULTS AND CONCLUSION: The combination of metabolomic and chemogenomic profiling, along with data analyses carried out using a novel computational method, could robustly identify the enzymes targeted by five drugs. Moreover, this novel computational method has the potential to identify genes that are causative of metabolomic differences or drug targets.


Subject(s)
Metabolic Networks and Pathways , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Computational Biology , Drug Delivery Systems , Gene Expression Profiling , Metabolomics , Saccharomyces cerevisiae/drug effects
3.
Cell Metab ; 7(2): 148-58, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18249174

ABSTRACT

Ceramides and sphingoid long-chain bases (LCBs) are precursors to more complex sphingolipids and play distinct signaling roles crucial for cell growth and survival. Conserved reactions within the sphingolipid biosynthetic pathway are responsible for the formation of these intermediates. Components of target of rapamycin complex 2 (TORC2) have been implicated in the biosynthesis of sphingolipids in S. cerevisiae; however, the precise step regulated by this complex remains unknown. Here we demonstrate that yeast cells deficient in TORC2 activity are impaired for de novo ceramide biosynthesis both in vivo and in vitro. We find that TORC2 regulates this step in part by activating the AGC kinase Ypk2 and that this step is antagonized by the Ca2+/calmodulin-dependent phosphatase calcineurin. Because Ypk2 is activated independently by LCBs, the direct precursors to ceramides, our data suggest a model wherein TORC2 signaling is coupled with LCB levels to control Ypk2 activity and, ultimately, regulate ceramide formation.


Subject(s)
Cell Cycle Proteins/physiology , Ceramides/biosynthesis , Phosphatidylinositol 3-Kinases/physiology , Protein Kinases/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae Proteins/physiology , Fungal Proteins/metabolism , Oxidoreductases/metabolism , Signal Transduction , Yeasts
4.
Mol Biol Cell ; 18(8): 2779-94, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17507646

ABSTRACT

The TOR kinases are regulators of growth in eukaryotic cells that assemble into two distinct protein complexes, TORC1 and TORC2, where TORC1 is inhibited by the antibiotic rapamycin. Present models favor a view wherein TORC1 regulates cell mass accumulation, and TORC2 regulates spatial aspects of growth, including organization of the actin cytoskeleton. Here, we demonstrate that in yeast both TORC1 and TORC2 fractionate with a novel form of detergent-resistant membranes that are distinct from detergent-resistant plasma membrane "rafts." Proteomic analysis of these TOR-associated membranes revealed the presence of regulators of endocytosis and the actin cytoskeleton. Genetic analyses revealed a significant number of interactions between these components and TORC1, demonstrating a functional link between TORC1 and actin/endocytosis-related genes. Moreover, we found that inhibition of TORC1 by rapamycin 1) disrupted actin polarization, 2) delayed actin repolarization after glucose starvation, and 3) delayed accumulation of lucifer yellow within the vacuole. By combining our genetic results with database mining, we constructed a map of interactions that led to the identification of additional genetic interactions between TORC1 and components involved in membrane trafficking. Together, these results reveal the broad scope of cellular processes influenced by TORC1, and they underscore the functional overlap between TORC1 and TORC2.


Subject(s)
Actins/metabolism , Cell Cycle Proteins/metabolism , Cell Membrane/enzymology , Phosphatidylinositol 3-Kinases/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Biological Transport/drug effects , Biomarkers/metabolism , Cell Membrane/drug effects , Cell Polarity/drug effects , Cytoskeleton/drug effects , Detergents/pharmacology , Endocytosis/drug effects , Gene Regulatory Networks/drug effects , Glucose/deficiency , Octoxynol/pharmacology , Protein Binding/drug effects , Proteomics , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/drug effects , Sirolimus/pharmacology , Transport Vesicles/drug effects
5.
J Biol Chem ; 281(42): 31616-26, 2006 Oct 20.
Article in English | MEDLINE | ID: mdl-16923813

ABSTRACT

The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.


Subject(s)
Caffeine/pharmacology , Gene Expression Regulation, Fungal , Membrane Proteins/physiology , Phosphatidylinositol 3-Kinases/physiology , Phosphodiesterase Inhibitors/pharmacology , Phosphotransferases (Alcohol Group Acceptor)/physiology , Saccharomyces cerevisiae Proteins/physiology , Adenosine Triphosphate/chemistry , Amino Acid Sequence , Genes, Fungal/physiology , Membrane Proteins/genetics , Molecular Sequence Data , Mutation , Phosphatidylinositol 3-Kinases/chemistry , Phosphotransferases (Alcohol Group Acceptor)/chemistry , Protein Binding , Protein Structure, Tertiary , Saccharomyces cerevisiae , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Sequence Homology, Amino Acid
6.
J Biol Chem ; 279(45): 46527-35, 2004 Nov 05.
Article in English | MEDLINE | ID: mdl-15326168

ABSTRACT

The heterodimeric bZip/HLH transcription factors Rtg1p and Rtg3p regulate the expression of a concise set of metabolic genes (termed RTG target genes) required for de novo biosynthesis of glutamate and glutamine. Several components have now been identified that control both the intracellular localization as well as activity of the Rtg1p.Rtg3p complex, yet the precise upstream regulatory signals involved remain unclear. For example, it has been proposed that Rtg1p.Rtg3p activity is repressed by glutamate, acting through the mitochondrial retrograde response pathway or, alternatively, by glutamine, acting through the Tor kinase pathway. Here we demonstrate that RTG target gene regulation is remarkably complex, with glutamate and glutamine as well as ammonia collaborating as potentially distinct signals to regulate RTG target gene expression. We show that both Tor and these nutrient-based signals converge on Mks1p, the immediate upstream inhibitor of Rtg1p.Rtg3p, and that a direct correlation exists between the degree of Mks1p phosphorylation and the extent of RTG target gene repression. Finally, we find that Tor- and glutamine-mediated RTG-target gene repression can be experimentally uncoupled, indicating that glutamine and Tor act, at least in part, independently to inhibit this pathway.


Subject(s)
Gene Expression Regulation , Phosphatidylinositol 3-Kinases/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Repressor Proteins/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Signal Transduction , Transcription Factors/metabolism , Ammonia/pharmacology , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Blotting, Northern , Blotting, Western , DNA, Complementary/metabolism , Dimerization , Dose-Response Relationship, Drug , Gene Deletion , Genotype , Glutamic Acid/metabolism , Glutamine/metabolism , Humans , Microscopy, Fluorescence , Mitochondria/metabolism , Models, Biological , Nitrogen/metabolism , Oligonucleotide Array Sequence Analysis , Phosphorylation , Saccharomyces cerevisiae/metabolism , Sirolimus/pharmacology
7.
J Biol Chem ; 279(15): 14752-62, 2004 Apr 09.
Article in English | MEDLINE | ID: mdl-14736892

ABSTRACT

The Tor1p and Tor2p kinases, targets of the therapeutically important antibiotic rapamycin, function as components of two distinct protein complexes in yeast, termed TOR complex 1 (TORC1) and TORC2. TORC1 is responsible for a wide range of rapamycin-sensitive cellular activities and contains, in addition to Tor1p or Tor2p, two highly conserved proteins, Lst8p and Kog1p. By identifying proteins that co-purify with Tor1p, Tor2p, Lst8p, and Kog1p, we have characterized a comprehensive set of protein-protein interactions that define further the composition of TORC1 as well as TORC2. In particular, we have identified Tco89p (YPL180w) and Bit61p (YJL058c) as novel components of TORC1 and TORC2, respectively. Deletion of TOR1 or TCO89 results in two specific and distinct phenotypes, (i) rapamycin-hypersensitivity and (ii) decreased cellular integrity, both of which correlate with the presence of SSD1-d, an allele of SSD1 previously associated with defects in cellular integrity. Furthermore, we link Ssd1p to Tap42p, a component of the TOR pathway that is believed to act uniquely downstream of TORC1. Together, these results define a novel connection between TORC1 and Ssd1p-mediated maintenance of cellular integrity.


Subject(s)
Phosphatidylinositol 3-Kinases/chemistry , Phosphotransferases (Alcohol Group Acceptor)/chemistry , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae/metabolism , Adaptor Proteins, Signal Transducing , Alleles , Antibiotics, Antineoplastic/pharmacology , Electrophoresis, Polyacrylamide Gel , Fungal Proteins/chemistry , Gene Deletion , Mass Spectrometry , Microscopy, Immunoelectron , Phenotype , Plasmids/metabolism , Precipitin Tests , Protein Binding , Saccharomyces cerevisiae Proteins/metabolism , Sirolimus/pharmacology , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...